Loading...
•
Dec 31, 2019
Enovis Q4 2019 Earnings Report
Colfax reported positive sales growth in Medical Technology and improved Fabrication Technology margins.
Key Takeaways
Colfax Corporation reported Q4 2019 results with net sales of $888 million, a 54.5% increase year-over-year, driven by the acquisition of DJO. The company reported EPS of $0.24 and adjusted EPS of $0.61. The Medical Technology segment saw a 7.5% sales increase, while the Fabrication Technology segment improved adjusted EBITA margins by 320 basis points.
Reported EPS from continuing operations was $0.24, and adjusted EPS was $0.61.
Medical Technology segment sales grew by 7.5% year-on-year, including 7.8% organic improvement.
Fabrication Technology operating income and adjusted EBITA margins improved by over 300 basis points.
Reaffirmed 2020 adjusted EPS guidance of $2.10 to $2.20.
Enovis
Enovis
Forward Guidance
Colfax reaffirmed its 2020 adjusted EPS outlook of $2.10 to $2.20.